Prospects for lung-cancer screening

Lancet

Volumn 355, Issue 9204, 2000, Pages 592-593

  Mulshine, J L ^a   Henschke, C I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

AUTOANALYSIS; CANCER SCREENING; EARLY CANCER; HUMAN; LUNG CANCER; NOTE; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM ANALYSIS;

EID: 0034685162     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00398-0     Document Type: Note

References (16)

1. IE Smith Screening for lung cancer: time to think positive Lancet 354 1999 86 87
2. CI Henschke DI McCauley DF Yankelevitz Early Lung Cancer Action Project: overall design and findings from baseline screening Lancet 354 1999 99 105
3. M Kaneko CT scanning for lung cancer in Japan. International Conference on Prevention and Early Diagnosis of Lung Cancer Varese Italy Dec 9-10 144–48 1998 (also in press in Cancer ).
4. MS Tockman JS Mulshine S Piantadosi Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression Clin Cancer Res 3 1997 2237 2246
5. FS Bonelli TE Hartman SJ Swensen A Sherrick Accuracy of highresolution CT in diagnosing lung diseases AJR 170 1998 1507 1512
6. TS Tockman PK Gupta JD Myers Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells; a new approach to early lung cancer detection J Clin Oncol 6 1988 1685 1693
7. P Fielding L Turnbull W Prime M Walshaw JK Field Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection Clin Cancer Res 5 1999 4048 4052
8. L Mao RH Hruban JO Boyle M Tockman D Sidransky Detection of oncogene mutations in sputum precedes diagnosis of lung cancer Cancer Res 54 1994 1634 1637
9. JK Field Selection and validation of new lung cancer markers for the molecular-pathological assessment of individuals with a high risk of developing lung cancer Brambilla C Brambilla E Lung tumors: fundamental biology and clinical management 1999 Marcel Dekker, Inc New York 287 302
10. V Sundaresan P Ganly P Haselton p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus Oncogene 7 1992 1989 1997
11. J Hung Y Kishimoto K Sugio Allele-specific 3p deletions occur at an early-stage in the pathogenesis of lung carcinoma JAMA 273 1995 558 563
12. Y Kishimoto K Sugio JY Hung Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying nonsmall cell lung cancers J Natl Cancer Inst 87 1995 1224 1229
13. L Mao DJ Lee MS Tockman YS Erozan F Askin D Sidransky Microsatellite alterations as clonal markers for the detection of human cancer Proc Natl Acad Sci USA 91 1994 9871 9875
14. II Wistuba C Behrens S Milchgrub Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma Oncogene 18 1999 643 650
15. L Mao JS Lee JM Kurie Clonal genetic alterations in the lungs of current and former smokers J Natl Cancer Inst 89 1997 857 862
16. SA Belinsky KJ Nikula WA Palmisano Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc Natl Acad Sci USA 95 1998 11891 11896